The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A‐RIPK1‐dependent necroptosis
Open accessAbstract
Mechanisms that alter protein phosphatase 2A (PP2A)‐dependent lung tumour suppression via the I2PP2A/SET oncoprotein are unknown. We show here that the tumour suppressor ceramide binds I2PP2A/SET selectively in the nucleus and including its K209 and Y122 residues as determined by molecular modelling/simulations and site‐directed mutagenesis. Because I2PP2A/SET was found overexpressed, whereas ceramide was downregulated in lung tumours, a sphingolipid analogue drug, FTY720, was identified to mimick ceramide for binding and targeting I2PP2A/SET, leading to PP2A reactivation, lung cancer cell death, and tumour suppression in vivo . Accordingly, while molecular targeting of I2PP2A/SET by stable knockdown prevented further tumour suppression by FTY720, reconstitution of WT‐I2PP2A/SET expression restored this process. Mechanistically, targeting I2PP2A/SET by FTY720 mediated PP2A/RIPK1‐dependent programmed necrosis (necroptosis), but not by apoptosis. The RIPK1 inhibitor necrostatin and knockdown or genetic loss of RIPK1 prevented growth inhibition by FTY720. Expression of WT‐ or death‐domain‐deleted (DDD)‐RIPK1, but not the kinase‐domain‐deleted (KDD)‐RIPK1, restored FTY720‐mediated necroptosis in RIPK1 −/− MEFs. Thus, these data suggest that targeting I2PP2A/SET by FTY720 suppresses lung tumour growth, at least in part, via PP2A activation and necroptosis mediated by the kinase domain of RIPK1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
Sun, L., Wang, H., Wang, Z., He, S., Chen, S., Liao, D., Wang, L., Yan, J., Liu, W., Lei, X., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.031 · Cited by 2,698
Cho, Y., Challa, S., Moquin, D., Genga, R., Ray, T. D., Guildford, M., & Chan, F. K.-M. (2009) · Cell · doi:10.1016/j.cell.2009.05.037 · Cited by 2,435
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Cohen, J. A., Barkhof, F., Comi, G., Hartung, H.-P., Khatri, B. O., Montalban, X., Pelletier, J., Capra, R., Gallo, P., Izquierdo, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907839 · Cited by 2,204
Identification of RIP1 kinase as a specific cellular target of necrostatins
Degterev, A., Hitomi, J., Germscheid, M., Ch'en, I. L., Korkina, O., Teng, X., Abbott, D., Cuny, G. D., Yuan, C., Wagner, G., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.83 · Cited by 2,059
Holler, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, J.-L., Schneider, P., Seed, B., & Tschopp, J. (2000) · Nature Immunology · doi:10.1038/82732 · Cited by 1,938
Biologically active sphingolipids in cancer pathogenesis and treatment
Ogretmen, B., & Hannun, Y. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1411 · Cited by 1,213
Self-citationHitomi, J., Christofferson, D. E., Ng, A., Yao, J., Degterev, A., Xavier, R. J., & Yuan, J. (2008) · Cell · doi:10.1016/j.cell.2008.10.044 · Cited by 989
Wang, Z., Jiang, H., Chen, S., Du, F., & Wang, X. (2012) · Cell · doi:10.1016/j.cell.2011.11.030 · Cited by 949
Yeh, E., Cunningham, M., Arnold, H., Chasse, D., Monteith, T., Ivaldi, G., Hahn, W. C., Stukenberg, P. T., Shenolikar, S., Uchida, T., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1110 · Cited by 791
Necroptosis as an alternative form of programmed cell death
Christofferson, D. E., & Yuan, J. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.12.003 · Cited by 770
Protein phosphatase 2A regulatory subunits and cancer
Eichhorn, P. J. A., Creyghton, M. P., & Bernards, R. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.05.005 · Cited by 513
Seo, S.-B., McNamara, P., Heo, S., Turner, A., Lane, W. S., & Chakravarti, D. (2001) · Cell · doi:10.1016/s0092-8674(01)00196-9 · Cited by 481
The Myeloid Leukemia-associated Protein SET Is a Potent Inhibitor of Protein Phosphatase 2A
Li, M., Makkinje, A., & Damuni, Z. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11059 · Cited by 479
When Do Lasses (Longevity Assurance Genes) Become CerS (Ceramide Synthases)?
Pewzner-Jung, Y., Ben-Dor, S., & Futerman, A. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.r600010200 · Cited by 435
Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases
Billich, A., Bornancin, F., Dévay, P., Mechtcheriakova, D., Urtz, N., & Baumruker, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307687200 · Cited by 433
Herzog, F., Kahraman, A., Boehringer, D., Mak, R., Bracher, A., Walzthoeni, T., Leitner, A., Beck, M., Hartl, F.-U., Ban, N., et al. (2012) · Science · doi:10.1126/science.1221483 · Cited by 371
Multiple pathways regulated by the tumor suppressor PP2A in transformation
Westermarck, J., & Hahn, W. C. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.02.001 · Cited by 344
Neviani, P., Santhanam, R., Oaks, J. J., Eiring, A. M., Notari, M., Blaser, B. W., Liu, S., Trotta, R., Muthusamy, N., Gambacorti-Passerini, C., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31095 · Cited by 335
Self-citationBonapace, L., Bornhauser, B. C., Schmitz, M., Cario, G., Ziegler, U., Niggli, F. K., Schäfer, B. W., Schrappe, M., Stanulla, M., & Bourquin, J.-P. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39987 · Cited by 312
The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2
Paugh, S. W., Payne, S. G., Barbour, S. E., Milstien, S., & Spiegel, S. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01168-2 · Cited by 302
Long Chain Ceramides Activate Protein Phosphatase-1 and Protein Phosphatase-2A
Chalfant, C. E., Kishikawa, K., Mumby, M. C., Kamibayashi, C., Bielawska, A., & Hannun, Y. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.29.20313 · Cited by 300
LaMontagne, K., Littlewood-Evans, A., Schnell, C., O'Reilly, T., Wyder, L., Sanchez, T., Probst, B., Butler, J., Wood, A., Liau, G., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2001 · Cited by 295
Karathanassis, D., Stahelin, R. V., Bravo, J., Perisic, O., Pacold, C. M., Cho, W., & Williams, R. L. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf519 · Cited by 294
Self-citationNEMO and RIP1 Control Cell Fate in Response to Extensive DNA Damage via TNF-α Feedforward Signaling
Biton, S., & Ashkenazi, A. (2011) · Cell · doi:10.1016/j.cell.2011.02.023 · Cited by 262
Kudo, N., Kumagai, K., Tomishige, N., Yamaji, T., Wakatsuki, S., Nishijima, M., Hanada, K., & Kato, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709191105 · Cited by 210
Mukhopadhyay, A., Saddoughi, S. A., Song, P., Sultan, I., Ponnusamy, S., Senkal, C. E., Snook, C. F., Arnold, H. K., Sears, R. C., Hanniui, Y. A., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-120550 · Cited by 208
Self-citationRelationship between the structure of SET/TAF-Iβ/INHAT and its histone chaperone activity
Muto, S., Senda, M., Akai, Y., Sato, L., Suzuki, T., Nagai, R., Senda, T., & Horikoshi, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603762104 · Cited by 161
Berdyshev, E. V., Gorshkova, I., Skobeleva, A., Bittman, R., Lu, X., Dudek, S. M., Mirzapoiazova, T., Garcia, J. G. N., & Natarajan, V. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805186200 · Cited by 159
Stahelin, R. V., & Cho, W. (2001) · Biochemistry · doi:10.1021/bi0020325 · Cited by 154
Self-citationPchejetski, D., Böhler, T., Brizuela, L., Sauer, L., Doumerc, N., Golzio, M., Salunkhe, V. A., Teissié, J., Malavaud, B. A., Waxman, J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1388 · Cited by 150
Bielawski, J., Pierce, J. S., Snider, J. M., Rembiesa, B. M., Szulc, Z. M., & Bielawska, A. E. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6741-1_3 · Cited by 147
Self-citationSenkal, C. E., Ponnusamy, S., Manevich, Y., Meyers‐Needham, M., Saddoughi, S. A., Mukhopadyay, A., Dent, P., Bielawski, J., & Öğretmen, B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.287383 · Cited by 143
Self-citationRoberts, K. G., Smith, A. M., McDougall, F. K., Carpenter, H., Horan, M. P., Neviani, P., Powell, J. A., Thomas, D., Guthridge, M. A., Perrotti, D., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2544 · Cited by 133
Self-citationCeramide mediates caspase‐independent programmed cell death
Thon, L., Möhlig, H., Mathieu, S., Lange, A., Bulanova, E., Winoto‐Morbach, S., Schütze, S., Bulfone‐Paus, S., & Adam, D. (2005) · The FASEB Journal · doi:10.1096/fj.05-3726com · Cited by 123
Salas, A., Ponnusamy, S., Senkal, C. E., Meyers‐Needham, M., Selvam, S. P., Saddoughi, S. A., Apohan, E., Sentelle, R. D., Smith, C. D., Gault, C. R., et al. (2011) · Blood · doi:10.1182/blood-2010-08-300772 · Cited by 122
Self-citationLahiri, S., Park, H., Laviad, E. L., Lu, X., Bittman, R., & Futerman, A. H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807438200 · Cited by 119
Zhang, W., Yang, J., Liu, Y., Chen, X., Yu, T., Jia, J., & Liu, C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.013698 · Cited by 116
Sphingosine Kinase Inhibitors and Cancer: Seeking the Golden Sword of Hercules
Pyne, S., Bittman, R., & Pyne, N. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2364 · Cited by 89
Don, A. S., Martínez‐Lamenca, C., Webb, W. R., Proia, R. L., Roberts, E., & Rosen, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609124200 · Cited by 88
FTY720 produces caspase-independent cell death of acute lymphoblastic leukemia cells
Wallington-Beddoe, C. T., Hewson, J. W., Bradstock, K. F., & Bendall, L. J. (2011) · Autophagy · doi:10.4161/auto.7.7.15154 · Cited by 76
Saddoughi, S. A., Garrett-Mayer, E. S., Chaudhary, U. B., O’Brien, P. E., Afrin, L. B., Day, T. A., Gillespie, M. B., Sharma, A. K., Wilhoit, C. S. T., Bostick, R., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0930 · Cited by 71
Self-citationWeinlich, R., Dillon, C. P., & Green, D. R. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.09.002 · Cited by 70
Wooten, L. G., Song, P., Senkal, C. E., & Öğretmen, B. (2007) · The FASEB Journal · doi:10.1096/fj.07-8621com · Cited by 69
Self-citationLiu, Q., Alinari, L., Chen, C., Yan, F., Dalton, J. T., Lapalombella, R., Zhang, X., Mani, R., Lin, T. S., Byrd, J. C., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2484 · Cited by 56
RIP1 links inflammatory and growth factor signaling pathways by regulating expression of the EGFR
Ramnarain, D. B., Paulmurugan, R., Park, S., Mickey, B., Asaithamby, A., Saha, D., Kelliher, M. A., Mukhopadhyay, P., Banani, F., Madden, C. J., et al. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402268 · Cited by 23
Self-citation
Cited by
Sphingolipid metabolites in inflammatory disease
Maceyka, M., & Spiegel, S. (2014) · Nature · doi:10.1038/nature13475 · Cited by 1,277
Sphingolipid metabolism in cancer signalling and therapy
Ogretmen, B. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.96 · Cited by 1,207
Tong, X., Tang, R., Xiao, M., Xu, J., Wang, W., Zhang, B., Liu, J., Yu, X., & Shi, S. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01392-3 · Cited by 883
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 720
Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond
Kunkel, G. T., Maceyka, M., Milstien, S., & Spiegel, S. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4099 · Cited by 434
Metadata
- Authors
- Saddoughi, S. A., Gencer, S., Peterson, Y. K., Ward, K. E., Mukhopadhyay, A., Oaks, J., Bielawski, J., Szulc, Z. M., Thomas, R. J., Selvam, S. P., Senkal, C. E., Garrett‐Mayer, E., De Palma, R. M., Fedarovich, D., Liu, A., Habib, A. A., Stahelin, R. V., Perrotti, D., & Ogretmen, B.
- Venue
- EMBO Molecular Medicine
- Published
- 2012-11-25
- Volume
- 5
- Issue
- 1
- Pages
- 105-121
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- OpenAlex
- W1900480423
- Cited by
- 264
- References
- 45
- FWCI
- 6.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.